Lyerly, Herbert

Recent Publications

Zhou, X, Qiao, G, Wang, X, Song, Q, Morse, MA, Hobeika, A, Gwin, WR, Ren, J, & Lyerly, HK. (2018, February). CYP1A1 genetic polymorphism is a promising predictor to improve chemotherapy effects in patients with metastatic breast cancer treated with docetaxel plus thiotepa vs. docetaxel plus capecitabine. Cancer chemotherapy and pharmacology, 81 (2), 365-372.

Stilwell, JL, Hobeida, A, Birse, RT, Ericson, N, Ramirez, AB, Hummel, S, Irwin, D, Kaldjian, EP, & Lyerly, HK. (2018, February). Detection of mutations in single tumor cells collected by fine needle aspiration in a mouse xenograft breast cancer model using MALDI-TOF.

Crosby, EJ, Wei, J, Yang, XY, Lei, G, Wang, T, Liu, CX, Agarwal, P, Korman, AJ, Morse, MA, Gouin, K, Knott, SRV, Lyerly, HK, & Hartman, ZC. (2018, January 19). Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors (Accepted). OncoImmunology.

Song, Q, Ren, J, Zhou, X, Wang, X, Song, G, Hobeika, A, Yuan, Y, & Lyerly, HK. (2018, January). Circulating CD8+CD28- suppressor T cells tied to poorer prognosis among metastatic breast cancer patients receiving adoptive T-cell therapy: A cohort study. Cytotherapy, 20 (1), 126-133.

Shuptrine, CW, Ajina, R, Fertig, EJ, Jablonski, SA, Kim Lyerly, H, Hartman, ZC, & Weiner, LM. (2017, December). An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejection. Cancer immunology, immunotherapy : CII, 66 (12), 1529-1544.

Osada, T, Kaneko, K, Gwin, WR, Morse, MA, Hobeika, A, Pogue, BW, Hartman, ZC, Hughes, PF, Haystead, T, & Lyerly, HK. (2017, December). In Vivo Detection of HSP90 Identifies Breast Cancers with Aggressive Behavior. Clinical cancer research : an official journal of the American Association for Cancer Research, 23 (24), 7531-7542.

Jiang, N, Qiao, G, Wang, X, Morse, MA, Gwin, WR, Zhou, L, Song, Y, Zhao, Y, Chen, F, Zhou, X, Huang, L, Hobeika, A, Yi, X, Xia, X, Guan, Y, Song, J, Ren, J, & Lyerly, HK. (2017, September). Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study. Clinical cancer research : an official journal of the American Association for Cancer Research, 23 (17), 5066-5073.

Crowe, LB, Hughes, PF, Alcorta, DA, Osada, T, Smith, AP, Totzke, J, Loiselle, DR, Lutz, ID, Gargesha, M, Roy, D, Roques, J, Darr, D, Lyerly, HK, Spector, NL, & Haystead, TAJ. (2017, April). A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in Vivo. ACS chemical biology, 12 (4), 1047-1055.

Snyder, JC, Rochelle, LK, Ray, C, Pack, TF, Bock, CB, Lubkov, V, Lyerly, HK, Waggoner, AS, Barak, LS, & Caron, MG. (2017, April). Inhibiting clathrin-mediated endocytosis of the leucine-rich G protein-coupled receptor-5 diminishes cell fitness. The Journal of biological chemistry, 292 (17), 7208-7222.

Mook, RA, Ren, X-R, Wang, J, Piao, H, Barak, LS, Kim Lyerly, H, & Chen, W. (2017, March). Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis. Bioorganic & medicinal chemistry, 25 (6), 1804-1816.

View All Publications

Herbert Lyerly

Summary

Recent Publications